Insider Stock Trading History of Stejbach Mark


The following table details the trading activities (stock purchases, stock sales, and stock option exercises) reported to the Securities and Exchange Commission (SEC) by insider Stejbach Mark since year 2005. The trader's CIK number is 1487937. At the time of this reporting, Stejbach Mark is the Director of Flexion Therapeutics Inc . (stock ticker symbol FLXN). See this page for all insider trading activities at Flexion Therapeutics Inc .

Note that in the past Stejbach Mark also reported insider trading activities as an insider of the following companies:
Stock purchases, sales, and option exercises reported by insider Stejbach Mark since 2005.
  Trade Date   Symbol Company Name (Issuer) Trade Type     Shares       Price ($)   Value ($)
2017-06-16 FLXN Flexion Therapeutics Inc Buy 1,580 17.02 26,888
2017-06-08 ALKS Alkermes Plc. Sale 10,000 60.34 603,350
2017-06-08 ALKS Alkermes Plc. Option Ex 10,000 17.30 173,000
2017-05-28 ALKS Alkermes Plc. Option Ex 2,500 .00 0
2017-03-03 ALKS Alkermes Plc. Option Ex 2,812 .00 0
2017-03-01 ALKS Alkermes Plc. Option Ex 5,250 .00 0
2017-02-26 ALKS Alkermes Plc. Option Ex 2,625 .00 0
2017-01-09 ALKS Alkermes Plc. Sale 547 60.27 32,967
2017-01-09 ALKS Alkermes Plc. Option Ex 547 17.30 9,463
2017-01-04 ALKS Alkermes Plc. Option Ex 2,500 17.30 43,250
2017-01-05 ALKS Alkermes Plc. Option Ex 300 17.30 5,190
2017-01-04 ALKS Alkermes Plc. Sale 2,500 60.01 150,017
2017-01-06 ALKS Alkermes Plc. Option Ex 6,653 17.30 115,096
2017-01-05 ALKS Alkermes Plc. Sale 300 60.09 18,026
2017-01-06 ALKS Alkermes Plc. Sale 6,653 60.07 399,645
2016-11-10 ALKS Alkermes Plc. Option Ex 5,780 17.30 99,994
2016-10-05 ALKS Alkermes Plc. Option Ex 5,000 .00 0
2016-05-28 ALKS Alkermes Plc. Option Ex 2,500 .00 0
2016-03-03 ALKS Alkermes Plc. Option Ex 2,813 .00 0
2015-12-28 ALKS Alkermes Plc. Option Ex 10,000 17.30 173,000
2015-12-28 ALKS Alkermes Plc. Sale 10,000 80.24 802,390
2015-12-01 ALKS Alkermes Plc. Option Ex 18,000 17.30 311,400
2015-12-01 ALKS Alkermes Plc. Sale 18,000 72.89 1,311,984
2015-11-02 ALKS Alkermes Plc. Option Ex 18,000 17.30 311,400
2015-11-02 ALKS Alkermes Plc. Sale 18,000 72.25 1,300,554
2015-05-28 ALKS Alkermes Plc. Option Ex 2,500 .00 0
2015-04-15 ALKS Alkermes Plc. Option Ex 5,780 17.30 99,994
2015-03-03 ALKS Alkermes Plc. Option Ex 2,812 .00 0
2014-05-28 ALKS Alkermes Plc. Option Ex 2,500 .00 0
2014-01-15 ALKS Alkermes Plc. Option Ex 2,780 17.30 48,094
2013-12-26 ALKS Alkermes Plc. Option Ex 3,000 17.30 51,900
2012-11-13 ALKS Alkermes Plc. Buy 1,200 20.13 24,156
2010-04-09 TNGN Tengion Inc Buy 100 5.00 500

Insider trading activities including stock purchases, stock sales, and option exercises listed in the above table cannot be completely guaranteed as to their accuracy. For more information regarding the trades made by Stejbach Mark (Director of Flexion Therapeutics Inc at the time of this reporting) see the Securities and Exchange Commission (SEC) website.